Publication

Treatment of Tuberculosis with Rifamycin-containing Regimens in Immune-deficient Mice

Ming Zhang
2011
Journal Articles

Abstract

Rationale: Daily rifapentine plus isoniazid-pyrazinamide in mice infected with Mycobacterium tuberculosis produces cure in 3 months. Whether cure corresponds to latent infection contained by host immunity or true tissue sterilization is unknown.

Official source

Graph Chat

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Treatment of Tuberculosis with Rifamycin-containing Regimens in Immune-deficient Mice

Chat with Graph Search

The conceptual foundations of innate immunity: Taking stock 30 years later

Single-cell analysis of the interactions between Mycobacterium tuberculosis and macrophages

A common NFKB1 variant detected through antibody analysis in UK Biobank predicts risk of infection and allergy